Wendy Guy
Founder at PROCESSA PHARMACEUTICALS, INC.
Net worth: 48 036 $ as of 30/04/2024
Wendy Guy active positions
Companies | Position | Start | End |
---|---|---|---|
PROCESSA PHARMACEUTICALS, INC. | Chief Administrative Officer | 04/10/2017 | - |
Founder | 29/03/2011 | - | |
Promet Therapeutics LLC
Promet Therapeutics LLC Pharmaceuticals: MajorHealth Technology Promet Therapeutics LLC engage in the clinical stage biotechnology company that develops drug products to treat patients who have suboptimal or no treatment alternatives. The company was founded on September 16, 2015 and is headquartered in Ellicott City, MD. | Chief Administrative Officer | - | - |
Founder | - | - | |
Director/Board Member | - | - |
Career history of Wendy Guy
Former positions of Wendy Guy
Companies | Position | Start | End |
---|---|---|---|
QUESTCOR PHARMACEUTICALS INC | Corporate Officer/Principal | 01/10/2009 | 01/08/2014 |
AGI Therapeutics Plc
AGI Therapeutics Plc Pharmaceuticals: MajorHealth Technology AGI Therapeutics Plc provides pharmaceutical services. The firm engages in development and commercialization of differentiated drug products to treat unmet medical needs, including conditions which qualify for orphan drug status. The company was founded by John Devane and Patrick Ashe in 2003 and is headquartered in Dublin, Ireland. | Corporate Officer/Principal | 01/06/2005 | 01/11/2009 |
Training of Wendy Guy
Mount Wachusett Community College | Undergraduate Degree |
Statistics
International
United States | 4 |
Ireland | 2 |
2 |
Operational
Chief Administrative Officer | 2 |
Founder | 2 |
Corporate Officer/Principal | 2 |
Sectoral
Health Technology | 5 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
PROCESSA PHARMACEUTICALS, INC. | Health Technology |
Private companies | 3 |
---|---|
Questcor Pharmaceuticals, Inc.
Questcor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Questcor Pharmaceuticals, Inc. was engaged in development, marketing and sale of prescription drugs. It operated as a biopharmaceutical company which focuses on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. The company's primary product was H.P. Acthar Gel, an injectable drug for the treatment of proteinuria in the nephrotic syndrome of the idiopathic type, or NS, the treatment of acute exacerbations of multiple sclerosis, or MS, in adults, the treatment of infantile spasms, or IS, in infants and children under two years of age, and the treatment of certain rheumatology related conditions, including the treatment of the rare and closely related neuromuscular disorders dermatomyositis and polymyositis. Questcor Pharmaceuticals was founded in September 1992 and was headquartered in Anaheim, CA. | Health Technology |
AGI Therapeutics Plc
AGI Therapeutics Plc Pharmaceuticals: MajorHealth Technology AGI Therapeutics Plc provides pharmaceutical services. The firm engages in development and commercialization of differentiated drug products to treat unmet medical needs, including conditions which qualify for orphan drug status. The company was founded by John Devane and Patrick Ashe in 2003 and is headquartered in Dublin, Ireland. | Health Technology |
Promet Therapeutics LLC
Promet Therapeutics LLC Pharmaceuticals: MajorHealth Technology Promet Therapeutics LLC engage in the clinical stage biotechnology company that develops drug products to treat patients who have suboptimal or no treatment alternatives. The company was founded on September 16, 2015 and is headquartered in Ellicott City, MD. | Health Technology |
- Stock Market
- Insiders
- Wendy Guy
- Experience